Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
46,377,939
-
Total 13F shares
-
29,830,020
-
Share change
-
+642,132
-
Total reported value
-
$1,070,980,758
-
Put/Call ratio
-
1643%
-
Price per share
-
$35.90
-
Number of holders
-
201
-
Value change
-
+$25,890,372
-
Number of buys
-
120
-
Number of sells
-
78
Institutional Holders of Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) as of Q1 2022
As of 31 Mar 2022,
Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) was held by
201 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
29,830,020 shares.
The largest 10 holders included
BlackRock Inc., FEDERATED HERMES, INC., VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, STATE STREET CORP, Invesco Ltd., GEODE CAPITAL MANAGEMENT, LLC, FULLER & THALER ASSET MANAGEMENT, INC., MORGAN STANLEY, and Nuveen Asset Management, LLC.
This page lists
201
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.